Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RUPALL DIN 02456478

Status: Marketed
Holder: MEDEXUS PHARMACEUTICALS INC.
Molecule: RUPATADINE (RUPATADINE FUMARATE)
Available to quote

Health Canada record

Active ingredient(s)RUPATADINE (RUPATADINE FUMARATE) 1 MG
Dosage formSolution
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCR06AX28 RUPATADINE
Original market date20-Jan-2017
Current status date02-Feb-2023
SourceHealth Canada DPD

Establishment licence of the holder

Medexus Pharmaceuticals Inc. — licence 101526, currently licensed, last inspection rating C (2026-02-19).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing RUPATADINE (RUPATADINE FUMARATE)

DINProductCompanyFormStrengthStatus
02553155APO-RUPATADINEAPOTEX INCTabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02552604PMS-RUPATADINEPHARMASCIENCE INCTabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02560119RIVA-RUPATADINELABORATOIRE RIVA INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed
02456451RUPALLMEDEXUS PHARMACEUTICALS INC.TabletRUPATADINE (RUPATADINE FUMARATE) 10 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
300352023-02-02New Drug Submission (NDS)Administrative: Change in Product Ownership
237172020-06-04New Drug Submission (NDS)Administrative: Merger/Buy-out
182902016-07-20New Drug Submission (NDS)
Request a quote for RUPALL

How to read a Canadian DIN record